×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Heal... [20]
Institute of Ch... [12]
THE STATE KEY L... [10]
INSTITUTE OF APP... [1]
Faculty of Scien... [1]
Authors
CHEN MEIWAN [6]
TAM KIN YIP [5]
DAI YUNLU [4]
LU JINJIAN [3]
HU YUANJIA [2]
LEUNG CHUNG HANG [1]
More...
Document Type
Journal article [33]
Review article [2]
Date Issued
2024 [1]
2023 [7]
2022 [4]
2021 [7]
2020 [3]
2019 [1]
More...
Language
英語English [30]
Source Publication
ADMET & DMPK [2]
International Jo... [2]
Molecular Pharma... [2]
ACS Applied Mate... [1]
AMERICAN JOURNAL... [1]
Acta Pharmaceuti... [1]
More...
Indexed By
SCIE [27]
ESCI [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 35
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism
Journal article
Chen, Qi, Wang, Wen Yan, Xu, Qing Yang, Dai, Yan Fa, Zhu, Xing Yu, Chen, Zhao Yang, Sun, Ning, Leung, Chung Hang, Gao, Fei, Wu, Ke Jia. The enhancing effects of selenomethionine on harmine in attenuating pathological cardiac hypertrophy via glycolysis metabolism[J]. Journal of Cellular and Molecular Medicine, 2024, 28(19), e70124.
Authors:
Chen, Qi
;
Wang, Wen Yan
;
Xu, Qing Yang
;
Dai, Yan Fa
;
Zhu, Xing Yu
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
4.3
/
5.0
|
Submit date:2024/10/10
Cardiac Hypertrophy
Combination Therapy
Glycolysis Metabolism
Harmine
Selenomethionine
Combined inhibition of pyruvate dehydrogenase kinase 1 and hexokinase 2 induces apoptsis in non-small cell lung cancer cell models
Journal article
Guo, Yizhen, Lu, Xianchen, Zhou, Yan, Chen, Wen Hua, Tam, Kin Yip. Combined inhibition of pyruvate dehydrogenase kinase 1 and hexokinase 2 induces apoptsis in non-small cell lung cancer cell models[J]. Experimental Cell Research, 2023, 433(2), 113830.
Authors:
Guo, Yizhen
;
Lu, Xianchen
;
Zhou, Yan
;
Chen, Wen Hua
;
Tam, Kin Yip
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.3
/
3.3
|
Submit date:2024/01/02
Cancer Metabolism
Combination Therapy
Hk2
Nsclc
Pdk1
Co-delivery of dimeric camptothecin and chlorin e6 via polypeptide-based micelles for chemo-photodynamic synergistic therapy
Journal article
Guo, Zhaopei, Wong, Ka Hong, Li, Enze, Zhou, Xingzhi, Jiang, Di, Gao, Jiebing, Chen, Meiwan. Co-delivery of dimeric camptothecin and chlorin e6 via polypeptide-based micelles for chemo-photodynamic synergistic therapy[J]. Chinese Medicine (United Kingdom), 2023, 18(1), 133.
Authors:
Guo, Zhaopei
;
Wong, Ka Hong
;
Li, Enze
;
Zhou, Xingzhi
;
Jiang, Di
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
5.3
/
5.5
|
Submit date:2024/01/02
Camptothecin
Chemo-photodynamic Therapy
Combination Cancer Therapy
Polypeptide
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov
Journal article
Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov[J]. Discover Oncology, 2023, 14(1), 151.
Authors:
Yang, Jing
;
Kang, Heming
;
Lyu, Liyang
;
Xiong, Wei
;
Hu, Yuanjia
Favorite
|
TC[WOS]:
7
TC[Scopus]:
7
|
Submit date:2023/09/21
Bispecific Antibodies
Combination Therapy
Immuno-oncology Therapy
Kinase Inhibitors
Pd-1/pd-l1 Inhibitors
Targeted Therapy
Epigallocatechin gallate circumvents drug induced resistance in non-small cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis
Journal article
Zhou, Yan, Huang, Shiqi, Guo, Yizhen, Ran, Maxoin, Shan, Wenying, Wen-Hau Chen, Tam, Kin Yip. Epigallocatechin gallate circumvents drug induced resistance in non-small cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis[J]. Phytotheraphy Research, 2023, 37(12), 5837-5853.
Authors:
Zhou, Yan
;
Huang, Shiqi
;
Guo, Yizhen
;
Ran, Maxoin
;
Shan, Wenying
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
7
IF:
6.1
/
7.0
|
Submit date:2023/08/22
Acquired Drug Resistance
Combination Therapy
Egcg
Egfr-tkis
Nsclc
Synergetic Effect
Active Ingredients from Chinese Medicine for Combination Cancer Therapy
Journal article
Xuan Wang, Jing Li, Ruie Chen, Ting Li, Meiwan Chen. Active Ingredients from Chinese Medicine for Combination Cancer Therapy[J]. International Journal of Biological Sciences, 2023, 19(11), 3499-3525.
Authors: ; et al.
Favorite
|
TC[WOS]:
13
TC[Scopus]:
13
IF:
8.2
/
8.3
|
Submit date:2023/08/21
Nanomedicine
Chinese Medicine
Active Ingredients
Combination Cancer Therapy
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:
Zhou,Jing Bo
;
Tang,Dongyang
;
He,Lin
;
Lin,Shiqi
;
Lei,Josh Haipeng
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
9.1
/
9.0
|
Submit date:2023/08/03
Bortezomib (Pubchem Cid: 387447)
Cepharanthine (Pubchem Cid: 10206)
Docetaxel (Taxotere) (Pubchem Cid: 11970251)
Drug Combination Therapy
Flunarizine Dihydrochloride (Pubchem Cid: 5282407)
Lapatinib Ditosylate (Pubchem Cid: 9941095)
Machine Learning
Pazopanib Hydrochloride (Pubchem Cid: 11525740)
Potential Combination Biomarkers
Tamoxifen Citrate (Pubchem Cid: 2733525)
Three-dimensional Tumor Slice Culture
Vatalanib (Pubchem Cid: 151194)
Vincristine (Pubchem Cid: 5978)
Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)
Tuning the photothermal properties of carbon dots in the deep-red to near-infrared wavelength regions for tumor therapy
Review article
2023
Authors:
Zhang,Tesen
;
Wu,Jun
;
Tang,Zikang
;
Qu,Songnan
Favorite
|
TC[WOS]:
9
TC[Scopus]:
7
IF:
6.0
/
6.0
|
Submit date:2023/08/03
Cancer-therapy
Emission
Chemotherapy
Combination
Absorption
Shift
Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol
Journal article
Bai, Long Bo, Yau, Lee Fong, Tong, Tian Tian, Chan, Wai Him, Zhang, Wei, Jiang, Zhi Hong. Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol[J]. Pharmacology Research and Perspectives, 2022, 10(4).
Authors:
Bai, Long Bo
;
Yau, Lee Fong
;
Tong, Tian Tian
;
Chan, Wai Him
;
Zhang, Wei
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
2.9
/
2.9
|
Submit date:2023/01/30
Combination Therapy
Ginsenosides
Lc-mrm
Nad++
Nmn
Resveratrol
Antimicrobial peptides–antibiotics combination: An effective strategy targeting drug-resistant Gram-negative bacteria
Journal article
Zhang, Fangyan, Zhong, Chao, Yao, Jia, Zhang, Jingying, Zhang, Tianyue, Li, Beibei, Gou, Sanhu, Ni, Jingman. Antimicrobial peptides–antibiotics combination: An effective strategy targeting drug-resistant Gram-negative bacteria[J]. Peptide Science, 2022, 114(4).
Authors:
Zhang, Fangyan
;
Zhong, Chao
;
Yao, Jia
;
Zhang, Jingying
;
Zhang, Tianyue
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
3
IF:
1.5
/
2.2
|
Submit date:2023/01/30
Anti-resistance Mechanisms
Antimicrobial Peptides
Antimicrobial Resistance
Combination Therapy
Gram-negative Bacteria